Exam 1 Flashcards
(93 cards)
Pharmacodynamics
The study of the effects of drugs on the body
Beneficence
the duty to protect research subjects from harm. It involves assessing potential risks and possible benefits and ensuring the benefits are greater than the risk.
Risk-Benefit Ratio
absorption
the movement of the drug into the bloodstream after administration
excipients
Fillers and inert substances—such as simple syrup, vegetable gums, aromatic powder, honey, and various elixirs
used in drug preparation to allow the drug to take on a particular size and shape and to enhance drug dissolution
Pharmacokinetics
The process of drug movement throughout the body that is necessary to achieve drug action
Pharmacogenetics
The study of genetic factors that influence an individual’s response to a specific drug
6 Rights of Medication Safety
- Right patient
- Right drug
- Right dose
- Right route
- Right time
- Right documentation
Chemical Name
Describes the chemical structure of the drug
› N-aceTYL-p-aminopheno
Generic Name
Official, nonproprietary name
Brand (Trade) Name
Proprietary name
Generic Drugs
› Must be approved by the FDA
› Same active ingredients as brand-name drug
› Usually less expensive
› May contain products that aid in providing the shape of the tablets, control the timing of release in the body
› Health care provider must state on prescription whether a generic drug can be substituted for the brand name drug
Over-the -Counter (OTC) Drugs
Drugs that have been found safe and appropriate for use without the direct supervision of a health care provider
› Important for the nurse to be aware of their clients use of OTC drugs
Enteric-coated (EC) drugs
resist disintegration in the gastric acid of the stomach
should not be crushed because crushing alters the place and time of absorption of the drug
ext/sustained-release (beaded) capsules
should not be crushed
Bioavailability
the percentage of administered drug available for activity orally administered drugs, bioavailability is affected by absorption and first-pass metabolism;
IV = 100%, PO = <100%
Factors that alter bioavailability
(1) drug form, such as tablet, capsule, sustained-release beads, liquid, transdermal patch, suppository, or inhalation
(2) route of administration (e.g., enteral, topical, or parenteral)
(3) gastric mucosa and motility;
(4) administration with food and other drugs; and
(5) changes in liver metabolism caused by liver dysfunction or inadequate hepatic blood flow
Distribution
the movement of the drug from the circulation to body tissues
protein binding
The portion of the drug bound to protein is inactive because it is not available to interact with tissue receptors and therefore is unable to exert a pharmacologic effect
Free drugs
are able to exit blood vessels and reach their site of action, causing a pharmacologic response;
primarily relevant when considering protein-bound drugs, but they can be a factor for any drug that binds to plasma proteins
Metabolism (biotransformation)
process by which the body chemically changes drugs into a form that can be excreted
primary site of metabolism
liver
half-life
time it takes for the amount of drug in the body to be reduced by half
Loading Dose
a large initial dose, known as a loading dose, that is significantly higher than maintenance dosing, therapeutic effects can be obtained while a steady state is reached
excretion
elimination of drugs from the body, is through the kidneys